Transcatheter valve-in-valve implantation is a feasible option for high-risk patients with failing surgical bioprostheses, though it carries significant periprocedural risks including mortality.
Answers are grounded in this paper and cite their sources.
May support valve-in-valve TAVI feasibility in select high-risk cases; leaves open periprocedural mortality reduction in prospective studies.
Objective: Transcatheter aortic heart valve-(THV)-in-valve-implantation is a method only few datas exist. Methods: We refer to 7 patients underwent an aortic valve replacement (AVR) several years ago with different kind of bioprothesis. According to a high perioperative risk for redo-AVR we decided on off-lable-use of valve-in-valve-implantation via THV. Results: Between 4/2008–8/2009, 245 patients were treated with Sapien™-THV by an interdisciplinary team, 7 patients (2.8%) needed a valve-in-valve implantation after previous AVR 6–12 years ago. The transapical (TA) method was taken in 5 patients whereas 2 patients were treated using the transfemoral (TF) access. 50% of the patients were female, mean age was 81.3 years, mean Euroscore 48.6% (27.5–83.8). There were 6 elective and 1 emergency cases; in 1 case the use of supporting ECC became necessary. Primary successful results without aortic insufficiency were seen in 6 patients, in 1 case a severe aortic regurgitation after valve-implantation caused by structural dysfunction had to be abolished by implanting an additional valve. In all 7 patients we didn't see conversions, neurological or vascular complications, re-thoracotomy or pace-maker-implantation. 2 patients died on the first post-interventional day (the emergency case (TA): Euroscore 83.8%, low cardiac output; one elective case (TF): myocardial infarction caused by left mean stenosis after procedural complication with acute PTCA). Conclusion: Patients with a severe aortic vitium after a previous AVR can be treated successfully with THV valve-in-valve-implantation by a skilled interdisciplinary team. For high risk patients this method offers an opportunity not free from complications.
No takes yet. Share an insight, caveat, or question.
Schröfel et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: